
BioLife Solutions BLFS
$ 35.53
1.27%
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
47.8 M |
Market Cap[1] |
$ 1.7 B |
EBITDA (LTM) |
$ -13.4 M |
P/E (LTM) |
54.73 |
P/S (LTM) |
14.8 |
EPS (LTM) |
0.62 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Haemonetics Corporation
HAE
|
$ 102.85 | 0.95 % | $ 4.85 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 1.44 | 0.34 % | $ 65.9 M | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 70.64 | 1.31 % | $ 14.1 B | NYSE,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Repligen Corporation
RGEN
|
$ 169.61 | 1.72 % | $ 9.54 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AtriCure
ATRC
|
$ 52.46 | 7.5 % | $ 2.5 B | Nasdaq Global Market,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 180.35 | 0.46 % | $ 10.3 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 8.0 | 0.06 % | $ 355 M | Nasdaq Global Market | ||
|
STAAR Surgical Company
STAA
|
$ 23.58 | 2.01 % | $ 1.17 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 226.83 | 0.83 % | $ 22.3 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 123.43 | 0.77 % | $ 3.95 B | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 15.47 | 0.09 % | $ 642 M | Nasdaq Global Select Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
ICU Medical
ICUI
|
$ 166.29 | 0.07 % | $ 4.1 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 12.18 | 0.33 % | $ 252 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 88.57 | 0.24 % | $ 5.24 B | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 27.59 | 0.73 % | $ 4.64 B | NYSE | ||
|
Pro-Dex
PDEX
|
$ 61.75 | 1.92 % | $ 203 B | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 25.57 | 0.86 % | $ 13.1 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 54.71 | 3.85 % | $ 3.69 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.39 | 0.72 % | $ 126 M | NYSE American | ||
|
ResMed
RMD
|
$ 229.19 | 0.12 % | $ 33.4 B | NYSE,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 369.83 | 0.28 % | $ 132 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 9.21 | 2.03 % | $ 78.1 K | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.47 | 1.08 % | $ 38.6 M | NYSE American | ||
|
West Pharmaceutical Services
WST
|
$ 342.73 | 0.03 % | $ 24.8 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 72.08 | 0.3 % | $ 35.5 B | NYSE | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.43 | 1.24 % | $ 2.28 B | Nasdaq Global Select Market,SPB | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.22 | 1.21 % | $ 149 M | Nasdaq Capital Market | ||
|
Nephros
NEPH
|
$ 4.18 | 0.95 % | $ 44.4 M | Nasdaq Global Select Market | ||
|
LeMaitre Vascular
LMAT
|
$ 80.49 | 0.22 % | $ 1.82 B | Nasdaq Global Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.58 | 2.27 % | $ 263 M | Nasdaq Global Select Market,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 187.62 | 0.05 % | $ 54 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.71 | 1.24 % | $ 21.3 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 139.96 | 0.35 % | $ 6.25 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 70.71 | 0.05 % | $ 229 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.